Bumetanide 0.5 MG Oral Tablet — RxCUI 197417
RxNorm drug concept · Semantic clinical drug
RxCUI 197417
Semantic clinical drug · SCD
● Current RxNorm concept 67 FDA products
126 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197417
Official nameBumetanide 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped67
Package NDCs mapped126
Reported Medicaid activity (SDUD)287,621 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bumetanide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is a water pill that helps your body get rid of extra fluid. It treats swelling from heart failure, liver disease and kidney disease. It comes as tablets, an injection and a nas...
- Follow your prescriber’s directions and the label. Tablets are usually taken once a day, and some people use an every-other-day schedule. Enbumyst is only for the nose and is meant...
- Muscle cramps, dizziness, low blood pressure, headache and nausea are the most common. Call your doctor if you feel very weak, confused or dehydrated, or notice ringing in your ear...
- Some medicines need extra care. Tell me if you take lithium, probenecid, indomethacin, aminoglycoside antibiotics, or blood pressure medicines. Always check with me before adding a...
🕸️ Concept Web — How Bumetanide 0.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bumetanide 0.5 MG Oral Tablet
RxCUI 197417 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Bumetanide
1808IN
-
Bumetanide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Bumex
203538BN
-
Bumex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bumetanide Oral Tablet
371158SCDF -
Bumetanide Oral Product
1151349SCDG -
Bumetanide Pill
1151350SCDG -
Bumetanide Oral Tablet [Bumex]
369375SBDF -
Bumex Oral Product
1168680SBDG -
Bumex Pill
1168681SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Bumetanide Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bumetanide 0.5 MG
315500SCDC -
Bumetanide 0.5 MG Oral Tablet [Bumex]
205488SBD -
Bumetanide 0.5 MG [Bumex]
566394SBDC
-
Bumetanide 0.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bumetanide 0.5 MG
SCDC · 315500 -
Bumetanide Oral Tablet
SCDF · 371158 -
Bumetanide Oral Product
SCDG · 1151349 -
Bumetanide Pill
SCDG · 1151350
Brand-Name Concepts
-
Bumetanide 0.5 MG Oral Tablet [Bumex]
SBD · 205488 -
Bumetanide 0.5 MG [Bumex]
SBDC · 566394 -
Bumetanide Oral Tablet [Bumex]
SBDF · 369375 -
Bumex Oral Product
SBDG · 1168680 -
Bumex Pill
SBDG · 1168681 -
Bumex
BN · 203538
📦 FDA Products & Package NDCs
67 products · 126 package NDCs
126 package NDCs map to RxCUI 197417 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00185-0128-01 | 100 TABLET in 1 BOTTLE (0185-0128-01) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00185-0128-05 | 500 TABLET in 1 BOTTLE (0185-0128-05) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00185-0129-01 | 100 TABLET in 1 BOTTLE (0185-0129-01) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00185-0129-05 | 500 TABLET in 1 BOTTLE (0185-0129-05) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00185-0130-01 | 100 TABLET in 1 BOTTLE (0185-0130-01) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00185-0130-05 | 500 TABLET in 1 BOTTLE (0185-0130-05) | Bumetanide | Sandoz Inc | 1996-11-21 |
| 00615-8614-39 | 30 TABLET in 1 BLISTER PACK (0615-8614-39) | Bumetanide | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-01-16 |
| 00615-8615-05 | 15 TABLET in 1 BLISTER PACK (0615-8615-05) | Bumetanide | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-01-15 |
| 00615-8615-39 | 30 TABLET in 1 BLISTER PACK (0615-8615-39) | Bumetanide | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-01-15 |
| 00615-8616-39 | 30 TABLET in 1 BLISTER PACK (0615-8616-39) | Bumetanide | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-01-15 |
| 00781-8099-01 | 100 TABLET in 1 BOTTLE (0781-8099-01) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00781-8099-05 | 500 TABLET in 1 BOTTLE (0781-8099-05) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00781-8113-01 | 100 TABLET in 1 BOTTLE (0781-8113-01) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00781-8113-05 | 500 TABLET in 1 BOTTLE (0781-8113-05) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00781-8160-01 | 100 TABLET in 1 BOTTLE (0781-8160-01) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00781-8160-05 | 500 TABLET in 1 BOTTLE (0781-8160-05) | Bumetanide | Sandoz Inc | 2026-06-03 |
| 00832-0541-10 | 1000 TABLET in 1 BOTTLE (0832-0541-10) | Bumetanide | Upsher-Smith Laboratories, LLC | 2018-01-30 |
| 00832-0541-11 | 100 TABLET in 1 BOTTLE (0832-0541-11) | Bumetanide | Upsher-Smith Laboratories, LLC | 2018-01-30 |
| 00832-0542-10 | 1000 TABLET in 1 BOTTLE (0832-0542-10) | Bumetanide | Upsher-Smith Laboratories, LLC | 2018-01-30 |
| 00832-0542-11 | 100 TABLET in 1 BOTTLE (0832-0542-11) | Bumetanide | Upsher-Smith Laboratories, LLC | 2018-01-30 |
| 16571-0677-01 | 100 TABLET in 1 BOTTLE (16571-677-01) | Bumetanide | Rising Pharma Holdings, Inc | 2024-06-03 |
| 16571-0677-10 | 1000 TABLET in 1 BOTTLE (16571-677-10) | Bumetanide | Rising Pharma Holdings, Inc | 2024-06-03 |
| 16571-0678-01 | 100 TABLET in 1 BOTTLE (16571-678-01) | Bumetanide | Rising Pharma Holdings, Inc | 2024-06-03 |
| 16571-0678-10 | 1000 TABLET in 1 BOTTLE (16571-678-10) | Bumetanide | Rising Pharma Holdings, Inc | 2024-06-03 |
| 16571-0679-01 | 100 TABLET in 1 BOTTLE (16571-679-01) | Bumetanide | Rising Pharma Holdings, Inc | 2024-06-03 |
| 23155-0900-01 | 100 TABLET in 1 BOTTLE (23155-900-01) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2025-07-15 |
| 23155-0900-05 | 500 TABLET in 1 BOTTLE (23155-900-05) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2025-07-15 |
| 23155-0900-10 | 1000 TABLET in 1 BOTTLE (23155-900-10) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2025-07-15 |
| 23155-0901-01 | 100 TABLET in 1 BOTTLE (23155-901-01) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 23155-0901-05 | 500 TABLET in 1 BOTTLE (23155-901-05) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 23155-0901-10 | 1000 TABLET in 1 BOTTLE (23155-901-10) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 23155-0902-01 | 100 TABLET in 1 BOTTLE (23155-902-01) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 23155-0902-05 | 500 TABLET in 1 BOTTLE (23155-902-05) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 23155-0902-10 | 1000 TABLET in 1 BOTTLE (23155-902-10) | bumetanide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2024-06-28 |
| 30698-0630-01 | 100 TABLET in 1 BOTTLE (30698-630-01) | Bumex | Validus Pharmaceuticals LLC | 1983-02-28 |
| 30698-0631-01 | 100 TABLET in 1 BOTTLE (30698-631-01) | Bumex | Validus Pharmaceuticals LLC | 1983-02-28 |
| 30698-0631-05 | 500 TABLET in 1 BOTTLE (30698-631-05) | Bumex | Validus Pharmaceuticals LLC | 2024-01-17 |
| 30698-0632-01 | 100 TABLET in 1 BOTTLE (30698-632-01) | Bumex | Validus Pharmaceuticals LLC | 1983-02-28 |
| 30698-0632-05 | 500 TABLET in 1 BOTTLE (30698-632-05) | Bumex | Validus Pharmaceuticals LLC | 2024-01-17 |
| 42799-0119-01 | 100 TABLET in 1 BOTTLE (42799-119-01) | Bumetanide | Edenbridge Pharmaceuticals LLC. | 2015-10-15 |
| 42799-0120-01 | 100 TABLET in 1 BOTTLE (42799-120-01) | Bumetanide | Edenbridge Pharmaceuticals LLC. | 2015-10-15 |
| 42799-0120-02 | 500 TABLET in 1 BOTTLE (42799-120-02) | Bumetanide | Edenbridge Pharmaceuticals LLC. | 2015-10-15 |
| 42799-0121-01 | 100 TABLET in 1 BOTTLE (42799-121-01) | Bumetanide | Edenbridge Pharmaceuticals LLC. | 2015-10-15 |
| 42799-0121-02 | 500 TABLET in 1 BOTTLE (42799-121-02) | Bumetanide | Edenbridge Pharmaceuticals LLC. | 2015-10-15 |
| 43547-0896-10 | 100 TABLET in 1 BOTTLE (43547-896-10) | Bumetanide | Solco Healthcare LLC | 2025-03-01 |
| 43547-0897-10 | 100 TABLET in 1 BOTTLE (43547-897-10) | Bumetanide | Solco Healthcare LLC | 2025-03-01 |
| 43547-0897-50 | 500 TABLET in 1 BOTTLE (43547-897-50) | Bumetanide | Solco Healthcare LLC | 2025-03-01 |
| 43547-0898-10 | 100 TABLET in 1 BOTTLE (43547-898-10) | Bumetanide | Solco Healthcare LLC | 2025-03-01 |
| 43547-0898-50 | 500 TABLET in 1 BOTTLE (43547-898-50) | Bumetanide | Solco Healthcare LLC | 2025-03-01 |
| 50090-5664-00 | 90 TABLET in 1 BOTTLE (50090-5664-0) | Bumetanide | A-S Medication Solutions | 2021-09-15 |
Observed labelers:
Zydus Lifesciences Limited (15) ·
Zydus Pharmaceuticals (USA) Inc. (15) ·
Sandoz Inc (12) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (9) ·
Amneal Pharmaceuticals NY LLC (6) ·
Edenbridge Pharmaceuticals LLC. (5)
· +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.